Cargando…
Rizatriptan for the acute treatment of migraine: Consistency, preference, satisfaction, and quality of life
Rizatriptan is a 5HT (IB/ID) agonist with proven efficacy in the acute treatment of migraine headache. We performed a systematic review of the literature for clinical trials of rizatriptan incorporating important patient outcomes including consistency of response, preference, satisfaction, and quali...
Autores principales: | Amoozegar, Farnaz, Pringsheim, Tamara |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778411/ https://www.ncbi.nlm.nih.gov/pubmed/19936168 |
Ejemplares similares
-
Rizatriptan in the treatment of migraine
por: Láinez, Miguel JA
Publicado: (2006) -
Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine
por: Krymchantowski, Abouch Valenty, et al.
Publicado: (2004) -
A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine
por: Savi, Lidia, et al.
Publicado: (2010) -
Arterial spin-labeled MRI study of migraine attacks treated with rizatriptan
por: Kato, Yuji, et al.
Publicado: (2010) -
Rizatriptan vs. ibuprofen in migraine: a randomised placebo-controlled trial
por: Misra, Usha Kant, et al.
Publicado: (2007)